We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
This is the first big week of earnings season and that means we’ll get a lot of big cap companies reporting, including several Dow components.
These five companies, in various industries, lead off the charge as several have some of the best charts of not only this week, but of the entire earnings season.
It’s not easy to beat every quarter for years. If they’ve done it, it means surviving various economic conditions and having management with a forward-thinking vision.
Can these five keep up their winning streaks?
5 of the Best Big Cap Earnings Charts
1. Johnson & Johnson (JNJ - Free Report) has kept its earnings beat streak alive. It hasn’t missed in over 5 years. Shares are off in 2018, as the stock market has pulled back. Will it get a boost from earnings?
2. UnitedHealth Group (UNH - Free Report) has one of the best charts on all of Wall Street. Shares are off the recent all-time highs. Is this a change in the growth stocks or is it just a pause as these big cap names move higher still?
3. IBM (IBM - Free Report) has beat 13 quarters in a row but shares have been stagnant for several years on worries about revenue growth. Will blockchain be IBM’s savior?
4. Intuitive Surgical (ISRG - Free Report) has been one of the hottest medical stocks for the last two years. It has beat 11 quarters in a row. But shares have paused in 2018. Is this a buying opportunity?
5. Lam Research (LRCX - Free Report) hasn’t missed in five years. It was a great performer in 2017 but volatility has hit the shares in 2018. Will this earnings report be just the boost it needs?
Investor Alert: Breakthroughs Pending
A medical advance is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating substantial revenue, and even more wondrous products are in the pipeline.
Cures for a variety of deadly diseases are in sight, and so are big potential profits for early investors. Zacks names 5 stocks to buy now.
Image: Bigstock
5 of the Best Big Cap Earnings Charts
This is the first big week of earnings season and that means we’ll get a lot of big cap companies reporting, including several Dow components.
These five companies, in various industries, lead off the charge as several have some of the best charts of not only this week, but of the entire earnings season.
It’s not easy to beat every quarter for years. If they’ve done it, it means surviving various economic conditions and having management with a forward-thinking vision.
Can these five keep up their winning streaks?
5 of the Best Big Cap Earnings Charts
1. Johnson & Johnson (JNJ - Free Report) has kept its earnings beat streak alive. It hasn’t missed in over 5 years. Shares are off in 2018, as the stock market has pulled back. Will it get a boost from earnings?
2. UnitedHealth Group (UNH - Free Report) has one of the best charts on all of Wall Street. Shares are off the recent all-time highs. Is this a change in the growth stocks or is it just a pause as these big cap names move higher still?
3. IBM (IBM - Free Report) has beat 13 quarters in a row but shares have been stagnant for several years on worries about revenue growth. Will blockchain be IBM’s savior?
4. Intuitive Surgical (ISRG - Free Report) has been one of the hottest medical stocks for the last two years. It has beat 11 quarters in a row. But shares have paused in 2018. Is this a buying opportunity?
5. Lam Research (LRCX - Free Report) hasn’t missed in five years. It was a great performer in 2017 but volatility has hit the shares in 2018. Will this earnings report be just the boost it needs?
Investor Alert: Breakthroughs Pending
A medical advance is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating substantial revenue, and even more wondrous products are in the pipeline.
Cures for a variety of deadly diseases are in sight, and so are big potential profits for early investors. Zacks names 5 stocks to buy now.
Click here to see them >>